PKLR expression was absent in the mesenchymal SNU449 cells, which predominantly expressed PKM2, which is the more abundant form of PK in cancer cells, conferring substantial benefits on the rapidly growing tumorigenic cells. This evidence concerns the gene PKM and cancer.